Background Gastric cancer is a leading cause of cancer death worldwide and has signifi cant ethnic and socioeconomic diff erences in distribution. Th e aim of this study was to compare clinicopathologic characteristics and survival between Hispanics (H) and non-Hispanic whites (NHW) with gastric cancer.
Introduction
Although the incidence of gastric cancer continues to decline, it remains a common cause of cancer-related deaths in the United States and the world [1, 2] . Approximately 22,220 patients are diagnosed annually in the United States [3] . While surgery remains the only curative option, 5-year survival of patients undergoing curative resection for gastric adenocarcinoma is 20-30% with a median survival of only 24 months. Despite the success of modern chemotherapy in the treatment of large bowel cancers, the 5-year survival of advanced gastric adenocarcinoma is 3.1% [4, 5] .
Several studies have evaluated the association between ethnicity and survival among patients with gastric cancer in the past 10 years, with a great number of studies trying to fi nd an explanation for the disparity in gastric cancer outcomes between Western and Eastern countries [6] [7] [8] [9] . Most of the studies concluded that Asian patients have higher incidence of gastric cancer but better outcome compared with other ethnic groups, with African Americans having the worse overall survival [6] [7] [8] [9] . More recent studies in Southern California and Texas revealed that Hispanic (H) patients may have distinct tumor characteristics and worse outcomes when compared with individuals from other ethnic backgrounds including patients of Asian descent [10] [11] [12] [13] [14] [15] . A retrospective study from the University of Texas, M.D. Anderson Cancer Center demonstrated unique features of gastric adenocarcinoma in the H population but ethnicity did not infl uence overall survival in that study [10] . Higher prevalence of predisposing risk factors including: Helicobacter pylori (H. pylori) infection, EpsteinBarr virus exposure as well as lack of preventive care services and diff erences in treatment were used to explain the divergent outcomes between H and other ethnic groups [12] [13] [14] [15] . Th e existing data on H with gastric cancer focuses on diff erences in incidence and prevalence, but they lack insight into the association between ethnicity, tumor characteristics and survival. A better understanding of the factors that may explain the racial and ethnic disparities in gastric cancer outcome appears necessary to potentially improve survival for patients at risk [16] [17] [18] . With the majority of North American studies focusing on the populations of Southern California and Texas, we found it essential to conduct an analysis of the heterogeneous H population in Hackensack, New Jersey. Th e objective of our study was to compare the clinicopathologic characteristics between H and non-Hispanic whites (NHW) with gastric adenocarcinoma, with the goal of determining the association between ethnicity, clinicopathologic features and survival in our patient population.
Patients and methods
With approval of the Institutional Review Board and in accordance with Health Insurance Portability and Accountability Act regulations, we conducted a retrospective review of all patients diagnosed with gastric adenocarcinoma between January 1999 and March 2013 at the John Th eurer Cancer Center (JTCC) at Hackensack University Medical Center. Diagnosis of gastric adenocarcinoma was made according to the 2010 World Health Organization (WHO) and the American Joint Committee on Cancer (AJCC) histologic stage classifi cation of gastric carcinoma. In order to be included in the study the following characteristics were required: initial diagnosis of gastric adenocarcinoma had to been made in our institution or confi rmed by our pathology department; age >18 years; precisely recorded: tumor location, stage and histologic subtype; follow up at our institution aft er initial treatment (surgery, chemotherapy or radiation) (minimum 5 outpatient visits aft er the time of diagnosis); and accurately recorded vital status and time of death. Exclusion criteria comprised:history of prior malignancy or presence of metachronous tumors; patients with other gastric neoplasms, such as neuroendocrine tumors, lymphoma, or sarcoma; unknown ethnicity or racial self-identifi cation; gastric tumors with site classifi ed as "unspecifi ed" or histologic type classifi ed as "not otherwise specifi ed"; and patients diagnosed at the time of death or by autopsy.
Th e patient cohort was divided into two ethnic groups, H and NHW. We analyzed patient demographics, tumor clinicopathologic features, and overall survival. Tumor-related features included: primary tumor location divided into cardia, fundus, body, antrum, and pylorus, clinical and pathologic stage distributed between stages I to IV (based on AJCC 7 th edition), and histologic diff erentiation into well, moderate, poorly diff erentiated and undiff erentiated tumors. Treatment modalities included: chemotherapy only or radiotherapy only (no surgery); combined chemoradiation without surgery; surgical treatment only or surgical single-modality treatment (chemotherapy or radiotherapy); and surgical resection, including chemoradiation therapy and others. Recurrence rate and survival were calculated in months and analyzed.
Statistical analysis
Data analysis was performed using the SPSS statistical soft ware (SPSS for Windows, version 19.0, SPSS, Inc., Chicago, IL). Patient characteristics and pathologic features were compared by one-way analysis for continuous variable and the chi-square test was use for categorical variables. Multinomial logistic regression analysis was used to compare clinical and pathologic characteristics among the two ethnic groups. For survival calculations, the date of diagnosis was defi ned as the starting point and date of last follow up with an established vital status (death vs. alive) was defi ned as the endpoint. Median overall survival was obtained using the Kaplan-Meier method for both ethnic groups and univariate comparison between the two groups was carried out by using the log-rank test. Cox proportional hazard method was used to examine the eff ect of race and ethnicity on mortality and results were presented as hazard ratios (HRs) and 95% confi dence intervals (CIs). Variables considered in the Cox model included all relevant clinical and pathologic factors. Th e signifi cant level was set at 0.05 to identify the eff ect of possible prognostic factors on median overall survival.
Results
From 1999 to March of 2013, 807 patients were diagnosed with gastric adenocarcinoma at the JTCC, of which 638 patients met the inclusion criteria. Th ere were 101 H and 537 NHW with a median follow up of 24 months. Th e median age at diagnosis was 63 years in H and 69 years in NHW. A signifi cant diff erence in age was found in the Stage IV subgroup, with a median age at diagnosis of 54 years for H and 67 years for NHW (Table 1) .
When ethnic groups were compared by stage at presentation, H were more likely to present with advanced disease. Forty-eight percent of H had stage IV at the time of diagnosis compared with only 36% of NHW (P<0.03) ( Table 2 ). In addition, there was a signifi cant diff erence in the stage I group with only 9% of H having stage I disease at the time of diagnosis vs. 18% of the NHW (P<0.04, Table 2 ).
H were more likely to have distal tumors (antrum and pylorus) compared with NHW 44% vs. 15%, (P<0.0001). In contrast, cardia tumors were more common in the NHW group, 43% vs. 12% (P<0.0001) ( Table 2 ). H were more likely to present with poorly diff erentiated tumors compared with the NHW, with a marked diff erence of 70% vs. 50% (P<0.0002) ( Table 2 ). Diff use gastric cancer was more common in H patients than NHW (49% vs. 35%, P<0.04, Table 2 ).
Survival
H demonstrated worse survival compared to NHW, with a signifi cant diff erence in median overall survival of 64.5 months for H (95%CI: 45.8-83.0) and 107.6 months for NHW (95%CI: 94.9-120.3) (P<0.0001) (Fig. 1) (Fig. 3, Table 3 ). Although diff erences in survival did not reach statistical signifi cance for stages 1 and 4, H tended to have lower survival at early (stage 1) and advanced (stage 4) disease (Table 3) .
Univariate and multivariate analyses
Univariate and multivariate analyses were carried out to identify clinical and pathologic factors that predict median overall survival. Age, poor diff erentiation, stage and ethnicity were independent predictors of survival by multivariate Cox regression analysis (Table 4) .
Recurrence rates and disease progression
H had a higher recurrence rate than NHW 18% (n=18) versus 9% (48), P<0.003. Median time to primary recurrence was 14.1 months for H and 22.1 months for NHW. Gastric adenocarcinoma was the primary cause of death in 66% (n=67) of H versus 33% (177) of NHW (P<0.0001). From the entire cohort, only 18% (n=18) H versus 33% (n=177) of NHW were disease-free at the time of death (P<0.007).
Discussion
We observed signifi cant diff erences in presentation, tumor characteristics and survival in H and NHW with gastric adenocarcinoma. H patients were more likely to present with more advanced disease at a younger age and had a higher rate of distal and poorly diff erentiated tumors. Diff use subtype was also more prevalent in the H group and when comparing median overall survival, ethnicity was independent predictor of worse outcome. In concordance with our fi ndings, previous retrospective studies conducted in the southern parts of the United States (California and Texas) also demonstrated worse outcomes for the H population. For example, in 2012 Rajabi et al [15] studied 9949 patients with gastric cancer. Tumor pathobiology was found to vary by ethnicity, as NHW were more likely to have proximal tumors and less likely to have poorly diff erentiated or undiff erentiated tumors. However, ethnicity was not studied as a predictor of survival. Likewise, in 2005 Yao et al [14] reviewed the medical records of 1,897 patients with invasive gastric cancer. Th ey observed H were younger at the time of presentation when compared with other ethnic groups but in that study H ethnicity was not associated with gastric cancer survival when compared with other ethnic groups. In another study, Wu et al [11] who evaluated data from 37 cancer registries found that the rate of noncardia cancer was two times higher among H than NHW. Although our study did not evaluate some of the specifi c histologic patterns Th is could be partially explained by the higher incidence of H. pylori infection in the H population. Everhart et al [19] reported that H. pylori infection prevalence is three times higher in H than in NHW [12, 20] . Besides socio-economic factors, there is a new theory of hereditary susceptibility to H. pylori infection. Studies suggest that members of certain ethnic groups including H have a higher rate of infection than Caucasians even aft er socioeconomic diff erences are controlled [21] . Malaty et al [22] found a strong association between variants at the Toll-like receptor 10, 1, and 6 (TLR10/1/6) locus on chromosome 4 and H. pylori serologic status, which may contribute to the understanding of host susceptibility to a common infectious disease. Th is theory is still being investigated but it could explain the higher incidence of H. pylori infection in some ethnic groups. H. pylori infection has been linked to increased risk of gastric cancer and has a direct relationship to non-proximal gastric cancer, partially explaining the higher prevalence of these tumor characteristics in our H patients.
In accordance with several studies, we observed that H patients with gastric adenocarcinoma had a higher recurrence rate and were more likely to die of gastric adenocarcinoma. Some researchers have suggested the importance of some socio-economic factors [23] . It is important to note that H have one of the highest uninsured rates among ethnic groups in the United States and are less likely to receive preventive health care compared with NHW [24] . Th is disparity in healthcare access suggests that H would be more likely to have delays in diagnosis and to present with more advanced disease. Our study follows this trend with almost half of the H patients presenting with stage IV disease when compared with 36% of the NHW.
In contrast to prior publications, we observed ethnicity to be an independent factor predicting survival. Overall our H patients' median survival was approx. 40 months less than NHW. We also observed a signifi cant diff erence in survival aft er controlling for stage especially with our stage II and III patients. Receipt of chemotherapy and radiation, however, were not independent predictors of survival. Unmeasured factors, such as tumor biology and genetic mutations, have been proposed as important factors that could explain the racial diff erences in numerous malignancies, including gastric cancer, and could account for the observed diff erences in survival between the two ethnic groups in our study. Th e higher incidence of distal and diff use-type tumors in H could support this theory [25, 26] . Existing data suggests that diff erent pathophysiologic pathways lead to the development of the diff use and intestinal subtypes of gastric cancer. Defects in the cellular adhesion system are a characteristic of diff use gastric cancer. Th e cadherins and catenins play an important role in these derangements. Determining whether H have a higher rate of cadherin deletions or inactivating mutations would be an interesting follow-up study.
Th e current study is unique, because it includes a diverse sample of patients from the New Jersey area. In the 2010 census data on race and ethnicity, New Jersey was named the state with the nation's seventh largest H population. When compared with the population in the southern United States, New Jersey has a more balanced H population distribution (Caribbean 34%, Central and South American habitants 29% and 37%, respectively). In contrast, the H distribution in the Southern United States is skewed with 62% Central American (including Mexican, Guatemalan and Salvadorans), 23% South American and 15% Caribbean [27, 28] . Th is allows us to generate conclusions that could apply to a broader H patient population.
Th e limitations of this study are: 1) its retrospective design; 2) the relatively small sample size for H; 3) lack of data on environmental factors associated with ethnicity; and 4) inability to measure diff erences in tumor biology between ethnic groups by stage.
In summary, H were more likely to present at younger age and with more advanced gastric adenocarcinomas than NHW. Th e higher rate of diff use subtype and poorly diff erentiated tumors may explain some of the survival diff erences. Aft er accounting for age, histologic grade and stage; ethnicity was a signifi cant predictor of survival in our patient population. An ethnicity-based analysis of gastric cancer, such our study, acknowledges the intersection of biology, socioeconomic factors and access to health care with the natural history of the disease. Further research should aim to elucidate the basis of these diff erences, as this could alter management and improve survival.
